176 related articles for article (PubMed ID: 30374031)
1. Noninvasive paternal exclusion testing for cystic fibrosis in the first five to eight weeks of gestation.
Zeevi DA; Zahdeh F; Kling Y; Rosen T; Renbaum P; Ron-El R; Eldar-Geva T; Holzer HEG; Levy-Lahad E; Altarescu G
Sci Rep; 2018 Oct; 8(1):15941. PubMed ID: 30374031
[TBL] [Abstract][Full Text] [Related]
2. Genetic characterisation of circulating fetal cells allows non-invasive prenatal diagnosis of cystic fibrosis.
Saker A; Benachi A; Bonnefont JP; Munnich A; Dumez Y; Lacour B; Paterlini-Brechot P
Prenat Diagn; 2006 Oct; 26(10):906-16. PubMed ID: 16832834
[TBL] [Abstract][Full Text] [Related]
3. A Non-Invasive Droplet Digital PCR (ddPCR) Assay to Detect Paternal CFTR Mutations in the Cell-Free Fetal DNA (cffDNA) of Three Pregnancies at Risk of Cystic Fibrosis via Compound Heterozygosity.
Debrand E; Lykoudi A; Bradshaw E; Allen SK
PLoS One; 2015; 10(11):e0142729. PubMed ID: 26561302
[TBL] [Abstract][Full Text] [Related]
4. New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma.
Bustamante-Aragones A; Gallego-Merlo J; Trujillo-Tiebas MJ; de Alba MR; Gonzalez-Gonzalez C; Glover G; Diego-Alvarez D; Ayuso C; Ramos C
J Cyst Fibros; 2008 Nov; 7(6):505-10. PubMed ID: 18573697
[TBL] [Abstract][Full Text] [Related]
5. Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping.
Vermeulen C; Geeven G; de Wit E; Verstegen MJAM; Jansen RPM; van Kranenburg M; de Bruijn E; Pulit SL; Kruisselbrink E; Shahsavari Z; Omrani D; Zeinali F; Najmabadi H; Katsila T; Vrettou C; Patrinos GP; Traeger-Synodinos J; Splinter E; Beekman JM; Kheradmand Kia S; Te Meerman GJ; Ploos van Amstel HK; de Laat W
Am J Hum Genet; 2017 Sep; 101(3):326-339. PubMed ID: 28844486
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis transmembrane regulator haplotypes in households of patients with cystic fibrosis.
Furgeri DT; Marson FAL; Correia CAA; Ribeiro JD; Bertuzzo CS
Gene; 2018 Jan; 641():137-143. PubMed ID: 29054758
[TBL] [Abstract][Full Text] [Related]
7. Prenatal and newborn screening for CFTR mutations: the difficulties of prediction.
Schwarz MJ
Clin Biochem; 2011 May; 44(7):485-486. PubMed ID: 22036338
[No Abstract] [Full Text] [Related]
8. CFTR DeltaF508 mutation detection from dried blood samples in the first trimester of pregnancy: a possible routine prenatal screening strategy for cystic fibrosis?
Konialis CP; Hagnefelt B; Kazamia C; Karapanou S; Pangalos C
Fetal Diagn Ther; 2007; 22(1):41-4. PubMed ID: 17003555
[TBL] [Abstract][Full Text] [Related]
9. A New Targeted CFTR Mutation Panel Based on Next-Generation Sequencing Technology.
Lucarelli M; Porcaro L; Biffignandi A; Costantino L; Giannone V; Alberti L; Bruno SM; Corbetta C; Torresani E; Colombo C; Seia M
J Mol Diagn; 2017 Sep; 19(5):788-800. PubMed ID: 28736296
[TBL] [Abstract][Full Text] [Related]
10. Haplotype-based approach for noninvasive prenatal diagnosis of congenital adrenal hyperplasia by maternal plasma DNA sequencing.
Ma D; Ge H; Li X; Jiang T; Chen F; Zhang Y; Hu P; Chen S; Zhang J; Ji X; Xu X; Jiang H; Chen M; Wang W; Xu Z
Gene; 2014 Jul; 544(2):252-8. PubMed ID: 24768736
[TBL] [Abstract][Full Text] [Related]
11. Application of pyrosequencing to the identification of sequence variations in the cystic fibrosis transmembrane conductance regulator gene.
Mari C; Bruno F; Galbiati S; Torri A; Lombardo F; Seia M; Ferrari M; Restagno G; Cremonesi L
Clin Chem Lab Med; 2009; 47(9):1051-4. PubMed ID: 19728845
[TBL] [Abstract][Full Text] [Related]
12. A Broad Test Based on Fluorescent-Multiplex PCR for Noninvasive Prenatal Diagnosis of Cystic Fibrosis.
Guissart C; Tran Mau Them F; Debant V; Viart V; Dubucs C; Pritchard V; Rouzier C; Boureau-Wirth A; Haquet E; Puechberty J; Bieth E; Khau Van Kien P; Brechard MP; Raynal C; Girardet A; Claustres M; Koenig M; Vincent MC
Fetal Diagn Ther; 2019; 45(6):403-412. PubMed ID: 30121677
[TBL] [Abstract][Full Text] [Related]
13. A Cross-Sectional Study of the Marital Attitudes of Pregnant Women at Risk for Cystic Fibrosis and Psychological Impact of Prenatal Screening.
Popa ZL; Margan MM; Petre I; Bernad E; Stelea L; Chiriac VD; Craina M; Ciuca IM; Bina AM
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886548
[TBL] [Abstract][Full Text] [Related]
14. Prenatal Diagnosis of Cystic Fibrosis.
Fedick AM; Zhang J; Edelmann L; Kornreich R
Methods Mol Biol; 2019; 1885():221-231. PubMed ID: 30506201
[TBL] [Abstract][Full Text] [Related]
15. Antenatal Screening for CFTR Variants.
Vlachadis N; Vrachnis N
JAMA; 2023 Oct; 330(14):1388. PubMed ID: 37815573
[No Abstract] [Full Text] [Related]
16. Prenatal diagnosis of cystic fibrosis in a highly heterogeneous population.
Casals T; Gimenez J; Ramos MD; Nunes V; Estivill X
Prenat Diagn; 1996 Mar; 16(3):215-22. PubMed ID: 8710774
[TBL] [Abstract][Full Text] [Related]
17. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling.
Le Maréchal C; Audrézet MP; Quéré I; Raguénès O; Langonné S; Férec C
Hum Genet; 2001 Apr; 108(4):290-8. PubMed ID: 11379874
[TBL] [Abstract][Full Text] [Related]
18. Prenatal Diagnosis of Cystic Fibrosis by Celocentesis.
Giambona A; Vinciguerra M; Leto F; Cassarà F; Marchese G; Cigna V; Orlandi E; Mugavero ME; Cucinella G; Maggio A; Termini L; Makrydimas G; D'Alcamo E; Picciotto F
Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927598
[TBL] [Abstract][Full Text] [Related]
19. Antenatal Screening for CFTR Variants-Reply.
Ong T; Ramsey BW
JAMA; 2023 Oct; 330(14):1388-1389. PubMed ID: 37815569
[No Abstract] [Full Text] [Related]
20. Prenatal diagnosis of cystic fibrosis: 10-years experience.
Hadj Fredj S; Ouali F; Siala H; Bibi A; Othmani R; Dakhlaoui B; Zouari F; Messaoud T
Pathol Biol (Paris); 2015 Jun; 63(3):126-9. PubMed ID: 26002249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
